01 3AVELUMAB
02 1CETRORELIX (CETRORELIX ACETATE)
03 2CETRORELIX ACETATE
04 4CHORIOGONADOTROPIN ALFA
05 2CLADRIBINE
06 1CLOMIPHENE CITRATE
07 7FOLLITROPIN ALFA
08 12FOLLITROPIN ALFA/BETA
09 4INTERFERON BETA-1A
10 23LEVOTHYROXINE SODIUM
11 4LUTROPIN ALFA
12 7METFORMIN HYDROCHLORIDE
13 3MITOXANTRONE HYDROCHLORIDE
14 1PROGESTERONE
15 3SERMORELIN ACETATE
16 14SOMATROPIN
17 4SOMATROPIN RECOMBINANT
18 1TEPOTINIB (TEPOTINIB HYDROCHLORIDE)
19 1TEPOTINIB HYDROCHLORIDE
20 1WATER
01 32EMD SERONO
02 27EMD SERONO INC
03 28EMD SERONO, A DIVISION OF EMD INC., CANADA
04 11MERCK KGAA
01 1GEL
02 20INJECTABLE;INJECTION
03 1INJECTABLE;INTRAVENOUS
04 14INJECTABLE;SUBCUTANEOUS
05 6POWDER FOR SOLUTION
06 2POWDER;SUBCUTANEOUS
07 19SOLUTION
08 2TABLET
09 2TABLET, EXTENDED RELEASE;ORAL
10 31TABLET;ORAL
01 10.025MG
02 10.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
03 10.05MG
04 10.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
05 10.075MG
06 10.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
07 10.088MG
08 10.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
09 10.112MG
10 10.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
11 10.125MG
12 10.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
13 10.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
14 10.15MG
15 10.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
16 10.175MG
17 10.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
18 10.1MG
19 10.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
20 20.25MG/VIAL
21 10.2MG
22 10.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
23 20.3MG
24 11,050 IU/VIAL
25 210MG
26 1132MCG/1.5ML
27 1150 IU/0.25ML
28 2150 IU/VIAL
29 1150UNIT/0.48ML
30 11GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
31 11ML/KIT
32 320MG/ML
33 1225MG
34 1225UNIT/0.72ML
35 122MCG/0.5ML
36 2250MCG/0.5ML
37 1300 IU/0.5ML
38 1300UNIT/0.48ML
39 1300UNIT/0.5ML
40 237.5 IU/VIAL
41 144MCG/0.5ML
42 1450 IU/0.75ML
43 1450 IU/VIAL
44 1450UNIT/0.72ML
45 1450UNIT/0.75ML
46 1450UNIT/1.44ML
47 34MG/VIAL
48 15.5MCG/VIAL
49 15.83MG/ML
50 2500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
51 150MG
52 15MG/KIT
53 45MG/VIAL
54 1625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
55 166MCG/1.5ML
56 16MG/0.5ML (6MG/0.5ML)
57 36MG/VIAL
58 275 IU/VIAL
59 2750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
60 175UNIT/VIAL
61 18%
62 38.8MG/VIAL
63 1850MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
64 28MG/ML
65 1900 IU/1.5ML
66 1900UNIT/1.44ML
67 1900UNIT/1.5ML
68 1EQ 0.05MG BASE/AMP **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
69 1EQ 0.25MG /0.5ML
70 1EQ 0.25MG BASE/VIAL
71 1EQ 0.5MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
72 1EQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
73 1EQ 20MG BASE/10ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
74 1EQ 225MG BASE
75 1EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
76 1EQ 30MG BASE/15ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
77 1EQ 3MG BASE/VIAL
01 28Canada
02 70USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : BAVENCIO
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number : 761049
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;INTRAVENOUS
Brand Name : BAVENCIO
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number : 761078
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Canada
Dosage Form : SOLUTION
Brand Name : BAVENCIO
Dosage Strength : 20MG/ML
Packaging : 10ML VIAL
Approval Date :
Application Number : 2469723
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
CETRORELIX (CETRORELIX ACETATE)
Dosage Form : POWDER FOR SOLUTION
Brand Name : CETROTIDE
Dosage Strength : 0.25MG/VIAL
Packaging : 1ML
Approval Date :
Application Number : 2247766
Regulatory Info :
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Dosage Form : POWDER;SUBCUTANEOUS
Brand Name : CETROTIDE
Dosage Strength : EQ 0.25MG BASE/VIAL
Packaging :
Approval Date : 2000-08-11
Application Number : 21197
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : POWDER;SUBCUTANEOUS
Brand Name : CETROTIDE
Dosage Strength : EQ 3MG BASE/VIAL
Packaging :
Approval Date : 2000-08-11
Application Number : 21197
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : OVIDREL
Dosage Strength : 0.25MG/VIAL
Packaging :
Approval Date :
Application Number : 21149
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;SUBCUTANEOUS
Brand Name : OVIDREL
Dosage Strength : EQ 0.25MG /0.5ML
Packaging :
Approval Date :
Application Number : 21149
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Canada
Dosage Form : SOLUTION
Brand Name : OVIDREL
Dosage Strength : 250MCG/0.5ML
Packaging : 0.5ML
Approval Date :
Application Number : 2262088
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : SOLUTION
Brand Name : OVIDREL
Dosage Strength : 250MCG/0.5ML
Packaging : 0.5ML/3ML
Approval Date :
Application Number : 2371588
Regulatory Info :
Registration Country : Canada
